Achilles Therapeutics stock price, funding rounds, valuation and financials

Achilles Therapeutics has raised $138.11 m in total funding
Achilles Therapeutics Net income (FY, 2020)-33.2 M
Achilles Therapeutics EBIT (FY, 2020)-33.7 M
Achilles Therapeutics Cash, 31-Dec-2020177.8 M
Get notified regarding key financial metrics and revenue changes at Achilles TherapeuticsLearn more
Banner background

Achilles Therapeutics Funding

Summary Metrics

Founding Date

2016

Achilles Therapeutics total Funding

$138.1 m

Achilles Therapeutics latest funding size

$120.98 m

Time since last funding

2 years ago

Achilles Therapeutics investors

Achilles Therapeutics's latest funding round in September 2019 was reported to be $121 m. In total, Achilles Therapeutics has raised $138.1 m

Achilles Therapeutics Capital Raised

Embed Graph

Achilles Therapeutics Income Statement

Annual

USDFY, 2019FY, 2020

R&D expense

9.1m22.6m

General and administrative expense

4.7m11.1m

Operating expense total

13.8m33.7m

EBIT

(13.8m)(33.7m)

Pre tax profit

(14.0m)(33.2m)

Income tax expense

(3.0k)

Net Income

(14.0m)(33.2m)

EPS

(5.5)(7.9)

Achilles Therapeutics Balance Sheet

Annual

USDFY, 2019FY, 2020

Cash

97.6m177.8m

Accounts Receivable

5.5m9.9m

Current Assets

103.1m187.8m

PP&E

1.6m13.4m

Total Assets

105.2m218.9m

Accounts Payable

902.0k6.3m

Short-term debt

487.0k3.7m

Current Liabilities

3.9m16.6m

Long-term debt

12.3m

Non-Current Liabilities

12.9m

Total Debt

487.0k16.0m

Total Liabilities

3.9m29.5m

Additional Paid-in Capital

118.0m234.9m

Retained Earnings

(24.8m)(58.0m)

Total Equity

101.3m189.4m

Debt to Equity Ratio

0 x0.1 x

Debt to Assets Ratio

0 x0.1 x

Financial Leverage

1 x1.2 x

Achilles Therapeutics Cash Flow

Annual

USDFY, 2019FY, 2020

Net Income

(14.0m)(33.2m)

Depreciation and Amortization

302.0k772.0k

Cash From Operating Activities

(14.1m)(25.3m)

Purchases of PP&E

(942.0k)(11.8m)

Cash From Investing Activities

(942.0k)(11.8m)

Cash From Financing Activities

93.6m113.7m

Net Change in Cash

86.9m80.3m

Achilles Therapeutics Ratios

USDFY, 2019

Financial Leverage

1 x

Achilles Therapeutics Operating Metrics

FY, 2020May, 2021

Manufacturing Space, sq. ft.

64.18 k

Office and Laboratory Space, square feet

24.63 k

Trademarks (US)

3

Achilles Therapeutics Employee Rating

418 votes
Culture & Values
2.8
Work/Life Balance
3
Senior Management
2.6
Salary & Benefits
3.8
Career Opportunities
2.6
Source